Pilot study assessing the impact of smoking on nasal‐specific quality of life

P. Bousquet,P. Fabbro‐Peray,N. Janin,I. Annesi-Maesano,F. Neukirch,J. Daurès,J. Bousquet

DOI: https://doi.org/10.1111/j.1398-9995.2004.00579.x

2004-09-01

Abstract:oral allergy syndrome disappeared. The hepatitis vaccine was split in two doses (one-fifth of the total dose was followed by the remaining four-fifths of the dose 3 h later) and was administered without side-effects. Two booster doses were safely administered with this same procedure 1 and 5 months later. After 13 months of latex immunotherapy, the latex glove use test, initially positive (1), turned negative and specific IgE diminished from fourth to third radioallergosorbent test (RAST) class. The experience on latex immunotherapy is currently still quite limited and it is not well established when it would be convenient to stop this treatment (2, 3). However, on the basis of this report we conclude that the protocol we followed was safe and that it could be extremely useful in children severely allergic to latex who have to undergo vaccinations which are not stored in strictly latex-free vials.